LENSAR Past Earnings Performance
Past criteria checks 0/6
LENSAR's earnings have been declining at an average annual rate of -2.4%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 10.2% per year.
Key information
-2.4%
Earnings growth rate
58.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 10.2% |
| Return on equity | -30.5% |
| Net Margin | -34.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story
Feb 22
Here's Why We're Watching LENSAR's (NASDAQ:LNSR) Cash Burn Situation
Jan 24Not Many Are Piling Into LENSAR, Inc. (NASDAQ:LNSR) Just Yet
Dec 20Here's Why We're A Bit Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation
Oct 21Investors Continue Waiting On Sidelines For LENSAR, Inc. (NASDAQ:LNSR)
Sep 13This Broker Just Slashed Their LENSAR, Inc. (NASDAQ:LNSR) Earnings Forecasts
Mar 21Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?
Mar 18Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation
Nov 01LENSAR GAAP EPS of -$0.67, revenue of $8M
Aug 08LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans
Mar 23We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth
Jul 28LENSAR EPS misses by $0.23, beats on revenue
May 05What You Need To Know About LENSAR, Inc.'s (NASDAQ:LNSR) Investor Composition
Feb 25We're Keeping An Eye On LENSAR's (NASDAQ:LNSR) Cash Burn Rate
Jan 03Revenue & Expenses BreakdownBeta
How LENSAR makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 42 | -14 | 27 | 6 |
| 30 Sep 23 | 40 | -13 | 27 | 6 |
| 30 Jun 23 | 38 | -18 | 28 | 6 |
| 31 Mar 23 | 34 | -18 | 28 | 9 |
| 31 Dec 22 | 35 | -20 | 27 | 12 |
| 30 Sep 22 | 36 | -21 | 26 | 14 |
| 30 Jun 22 | 37 | -23 | 26 | 15 |
| 31 Mar 22 | 37 | -21 | 24 | 14 |
| 31 Dec 21 | 34 | -20 | 24 | 12 |
| 30 Sep 21 | 32 | -23 | 27 | 11 |
| 30 Jun 21 | 30 | -21 | 27 | 10 |
| 31 Mar 21 | 28 | -21 | 25 | 9 |
| 31 Dec 20 | 26 | -20 | 24 | 8 |
| 30 Sep 20 | 27 | -15 | 20 | 3 |
| 30 Jun 20 | 27 | -16 | 18 | 5 |
| 31 Mar 20 | 29 | -15 | 18 | 5 |
| 31 Dec 19 | 31 | -15 | 17 | 4 |
| 31 Dec 18 | 24 | -14 | 16 | 3 |
Quality Earnings: LNSR is currently unprofitable.
Growing Profit Margin: LNSR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LNSR is unprofitable, and losses have increased over the past 5 years at a rate of 2.4% per year.
Accelerating Growth: Unable to compare LNSR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LNSR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: LNSR has a negative Return on Equity (-30.49%), as it is currently unprofitable.